Accreditation for the Self-Directed Review in Genetic Cancer Risk Assessment (SDR)

CME credit is an optional add-on to this course. If you have elected to earn CME credit, review the following instructions:

After registering and paying for the course, you can then register and pay for the CME admin fee found at https://education.ccgcop.org/products/sdr2-verify-completion-and-earn-cme. You must complete all the bundles of the course (including all required video content, quizzes, assignments, evaluations, etc.) in any order. Each bundle will have a Bundle Completion Code provided at the end of the bundle. These codes must then be entered sequentially (bundle 1, then bundle 2, then bundle 3...) in the "Earn Your Certificate of Completion module" (found at the bottom of the https://education.ccgcop.org/SDR-002-bundles), which then unlocks the end-of-course evaluation. Completing the evaluation on or before 11:59 pm PT on June 1, 2026, will provide your CME credits and certificate.

Continuing education credits (CME) are awarded to participants who complete the entirety of this course on or before 11:59 pm PT on June 1, 2026. A certificate of completion is only awarded to participants who complete all required bundles, assignments, and evaluations on or before 11:59 pm PT on June 1, 2026. 

For more information, view the frequently asked questions page or contact us at CGEP@coh.org.
 

Continuing Education Accreditation

Download Learner Notification

City of Hope

2025/2026 CCGCoP Review Course

Date of CE Release: 6-01-2025

Date of CE Expiration: 06-01-2026

Location: Online

Acknowledgement of Financial Commercial Support

No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support

No in-kind commercial support was received for this educational activity.

Satisfactory Completion 

Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a speciality not listed below, it is your repsonsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and City of Hope. Amedco LLC is jointly accredited by the Accreditation Counsecil for COntiuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco Joint Accreditation Provider Number: 4008163

Professions in scope for this activity are listed below.

Physicians

Amedco LLC designates this material for a maximum of 34.0 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Objectives

1. Define the basic principles of gene structure, function, and regulation.
2. Describe fundamentals of the genetic cancer risk assessment (GCRA) process.
3. Explain the methods and limitations of genetic analysis for hereditary breast and ovarian cancer.
4. Recognize and apply mutation probability and empiric risk assessment models for breast cancer.
5. Recognize features associated with hereditary risk for colorectal and other gastrointestinal cancers.
6. Recognize clinical features of hereditary endocrine neoplasia syndromes.
7. Recognize clinical features of hereditary cancer syndromes with pediatric manifestations.
8. Identify genetic counseling and testing issues associated with pediatric hereditary cancer syndromes.
9. Define disease characteristics of hereditary syndromes classified as genodermatoses.
10. Compare Describe the differences between a high, moderate, and low penetrance cancer susceptibility gene.
11. Recognize ethical, legal and social issues relevant to cancer genetics counseling and testing.
12. Recognize key psychological principles and how they generalize across hereditary cancer syndromes. 

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed below.

Additional Help

For more information, view the frequently asked questions page or contact us at CGEP@coh.org.

CCGCoP Bootcamp